Allscripts Acquires Oasis Medical Solutions

AllscriptsAllscripts (NASDAQ: MDRX) announced the acquisition of privately-held Oasis Medical Solutions Limited, a London-based Patient Administration System (PAS) and health informatics solution provider. The OasisTM PAS system, developed over 18 years in partnership with numerous NHS trusts, provides flexible, efficient and scalable administrative workflow across all venues of care. By combining the Oasis PAS technology with the Allscripts Sunrise clinical platform, Allscripts will offer a highly competitive, single-source offering for an innovative and advanced electronic patient record solution throughout the United Kingdom.

The Oasis PAS is used extensively across the NHS in more than a dozen NHS trusts and hospitals. Clients include East Sussex Healthcare, Royal Surrey County Hospital Trust, Medway NHS Foundation Trust and Worcestershire Acute Hospitals NHS Trust, among others. Oasis hospital clients average over 500 beds per facility, and the company has distinguished itself for its exclusive focus on PAS solutions for the NHS trusts that are innovative, effective, affordable and flexible.

Allscripts has a proven track record of success for clinical solutions, specifically the Allscripts Sunrise clinical electronic health record for inpatient and outpatient care management. Today, Sunrise is live at Liverpool Heart and Chest Hospital NHS Foundation Trust as well as at Salford Royal NHS Foundation Trust. In addition, Allscripts recently announced the opening of its European headquarters in Manchester, UK, committing additional resources to this important healthcare market.

By combining a leading PAS offering with its advanced clinical solution, Allscripts will provide the UK NHS trusts with the clear long-term advantages of integrated workflow between PAS and clinical solutions and the benefit of one business partner that provides a single-source electronic patient record to improve the efficiency and quality of healthcare delivery.

"The United Kingdom is an important growth market for Allscripts core clinical and PAS solutions," said Richard Berner, President, Allscripts International. "A strong clinical offering combined with a highly regarded PAS provides a complete and proven solution to meet the critical long-term needs of the NHS Trusts. By acquiring Oasis, we believe we have optimised our position in the market and expect to drive significant value from this combination for our clients."

Terms of the acquisition were not disclosed.

About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of HealthTM. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

New AI Tool Accelerates mRNA-Based Treat…

A new artificial intelligence (AI) model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...